Pacer Advisors, Inc. Macrogenics Inc Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$9.77 - $21.47 $16,013 - $35,189	1,639 New	1,639 $24,000
Q2 2021 Jul 21, 2021	SELL	$20.49 - $35.63 $53,827 - $93,600	-2,627 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$18.99 - $33.2 $10,596 - $18,525	-558 Reduced 17.52%	2,627 $84,000
Q4 2020 Jan 20, 2021	BUY	$19.41 - $26.0 $40,217 - $53,872	2,072 Added 186.16%	3,185 $73,000
Q3 2020 Oct 19, 2020	BUY	$24.69 - $31.6 $27,479 - $35,170	1,113 New	1,113 $28,000
Q4 2018 Feb 13, 2019	SELL	$11.75 - $21.42 $34,756 - $63,360	-2,958 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$19.26 - $23.46 $56,971 - $69,394	2,958 New	2,958 $63,000
Q1 2018 May 14, 2018	SELL	$18.89 - $32.46 $10,389 - $17,853	-550 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$16.19 - $20.3 $8,904 - $11,165	550	550 $10,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $209M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.